ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

FBIO Fortress Biotech Inc

1.70
-0.02 (-1.16%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 104,621
Bid Price 1.67
Ask Price 4.00
News -
Day High 1.79

Low
1.24

52 Week Range

High
11.85

Day Low 1.70
Share Name Share Symbol Market Stock Type
Fortress Biotech Inc FBIO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.02 -1.16% 1.70 23:00:11
Open Price Low Price High Price Close Price Previous Close
1.71 1.70 1.79 1.72 1.72
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
861 104,621 US$ 1.73 US$ 180,796 - 1.24 - 11.85
Last Trade Type Quantity Price Currency
15:59:34 1 US$ 1.70 USD

Fortress Biotech Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
31.24M 18.38M - 84.51M -68.67M -3.74 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Fortress Biotech News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No FBIO Message Board. Create One! See More Posts on FBIO Message Board See More Message Board Posts

Historical FBIO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.861.861.661.76170,752-0.16-8.60%
1 Month2.052.0531.63061.84232,170-0.35-17.07%
3 Months1.952.6151.631.93293,782-0.25-12.82%
6 Months1.884.431.242.29562,374-0.18-9.57%
1 Year10.9511.851.245.06559,505-9.25-84.47%
3 Years64.8071.851.2420.91535,425-63.10-97.38%
5 Years26.4091.501.2435.57653,361-24.70-93.56%

Fortress Biotech Description

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Targadox, Exelderm, Ceracade, Luxamend, and Dermasorb. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

Your Recent History

Delayed Upgrade Clock